Envista Holdings Corp at JPMorgan Healthcare Conference Transcript
Perfect. Hi, everyone. This is Rachel Vatnsdal from the JPMorgan Tools and Diagnostics team. Today with me, I have Amir Aghdaei from the Envista team along with Howard. And so first, we're going to start off with a presentation with a presentation from management and then followed by Q&A. So during the Q&A session, you either can submit questions online through the portal. For those of you watching the webcast or if you're here in person, feel free to raise your hand. We do have mic runners with mics. So just make sure to raise your hands.
Thank you so much. Thanks for having us in here. Good to be back again and happy new year to all of you. I wanted to give you a little bit of a perspective of Envista, we have been in public market for over 3 years now. We came out of Danaher as a spin-off. And I'll give you a little bit of a feel for the company itself, the performance and what we see happening
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |